Press Releases

05.06.2021

Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games

05.04.2021

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

04.28.2021

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

04.28.2021

Pfizer Acquires Amplyx Pharmaceuticals

04.28.2021

Pfizer Acquires Amplyx Pharmaceuticals

04.22.2021

Pfizer Declares Second-Quarter 2021 Dividend

04.19.2021

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®

04.15.2021

Pfizer Invites Shareholders to Attend Virtual-Only 2021 Annual Meeting of Shareholders on April 22

04.12.2021

Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study Evaluating Contraceptive Efficacy of Once-Daily Relugolix Combination Tablet

04.07.2021

Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for the Treatment of Moderate to Severe Atopic Dermatitis

04.02.2021

Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Review Oncology Business on April 9, 2021

04.01.2021

Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study